1
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
Condition(s):Opioid-Related DisordersLast Updated:January 12, 2017Completed
Buprenorphine and Naloxone: 197 Clinical Trials, Page 1 of 20
Hide Studies Not Open or Pending
2
Buprenorphine and Naloxone Combination Study – 10
Condition(s):Heroin Dependence; Opioid-Related DisordersLast Updated:January 12, 2017Completed
3
Effects of Buprenorphine and Naloxone in Opiate Addicts – 4
Condition(s):Opioid-Related Disorders; Substance-Related DisordersLast Updated:January 12, 2017Completed
4
Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
Condition(s):Opiate DependenceLast Updated:January 21, 2009Completed
5
Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
Condition(s):Opiate DependenceLast Updated:September 3, 2015Completed
6
Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
Condition(s):Hepatic Failure; Hepatic Impairment; Chronic Hepatitis C Infection With Hepatic ComaLast Updated:October 24, 2016Completed
7
Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects
Condition(s):Opioid DependenceLast Updated:May 4, 2017Withdrawn
8
Buprenorphine and Naloxone for the Treatment of Opiate Dependence – 1
Condition(s):Heroin Dependence; Substance-Related DisordersLast Updated:January 16, 2017Completed
9
Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder
Condition(s):Opioid Use DisorderLast Updated:April 24, 2018Completed
10
Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder
Condition(s):Healthy Volunteer; Opioid-use DisorderLast Updated:October 7, 2021Not yet recruiting